Camille L. Bedrosian - Insider Trading & Ownership

Entity
Individual
Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, California
Summary
The estimated net worth of Camille L. Bedrosian is at least $4.45 M dollars as of June 25, 2024. Camille L. Bedrosian is the Chief Medical Officer of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $2.91 M. Camille L. Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $981 K. Camille L. Bedrosian is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $446 K. Camille L. Bedrosian is the Director of RHYTHM PHARMACEUTICALS, INC. and owns shares of RHYTHM PHARMACEUTICALS, INC. (RYTM) stock worth about $117 K.
All Insider Reports
All Insider Reports

Ownership of Camille L. Bedrosian

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AMLX Amylyx Pharmaceuticals, Inc. Chief Medical Officer $2.91 M Apr 16, 2024
RARE Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer $981 K Mar 1, 2023
CRNX Crinetics Pharmaceuticals, Inc. Director $446 K Jun 7, 2024
RYTM RHYTHM PHARMACEUTICALS, INC. Director $117 K Jun 21, 2024

Insider Transactions Reported by Camille L. Bedrosian:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership